Literature DB >> 29030756

A Herald of Plasma Cell Myeloma: A Report of Malignant Plasma Cells Identified in Parathyroid Adenoma and a Review of Non-parathyroid Malignancies in Parathyroid Glands.

Vincent Cracolici1, Raymon H Grogan2, Madina Sukhanova3, Jason X Cheng4, Sandeep Gurbuxani4, Nicole A Cipriani4.   

Abstract

Involvement of the parathyroid glands by non-parathyroid neoplasia is an infrequent event. Rare cases of metastases to the parathyroid gland have been reported in parathyroidectomies and autopsies of patients with known solid or hematopoietic malignancies. Here, we present a case of atypical clonal plasma cells incidentally identified within a parathyroid adenoma resected for hyperparathyroidism and hypercalcemia, which served as the sentinel event for a subsequent diagnosis of plasma cell myeloma. To our knowledge, this is the only reported case of a hematopoietic malignancy involving a parathyroid adenoma and the only reported case of malignant hematopoietic cells initially detected in parathyroidectomy.

Entities:  

Keywords:  Hypercalcemia; Incidental; Myeloma; Parathyroid adenoma

Mesh:

Year:  2017        PMID: 29030756      PMCID: PMC5953883          DOI: 10.1007/s12105-017-0861-7

Source DB:  PubMed          Journal:  Head Neck Pathol        ISSN: 1936-055X


  24 in total

1.  Tumor-to-tumor metastasis: Hepatocellular carcinoma metastatic to parathyroid adenoma.

Authors:  Hee Eun Lee; Dong Hoon Kim; Young Hye Cho; Kyungeun Kim; Seoung Wan Chae; Jin Hee Sohn
Journal:  Pathol Int       Date:  2011-08-04       Impact factor: 2.534

2.  Metastatic breast carcinoma to parathyroid adenoma on fine needle cytology sample: report of a case.

Authors:  Franco Fulciniti; Luciano Pezzullo; Maria Grazia Chiofalo; Daniela Butera; Nunzia Simona Losito; Antonio Pasquale Tommaselli; Gerardo Botti
Journal:  Diagn Cytopathol       Date:  2010-11-28       Impact factor: 1.582

3.  Incidence, Risk Factors, and Clinical Outcomes of Incidental Parathyroidectomy During Thyroid Surgery.

Authors:  Megan K Applewhite; Michael G White; Maggie Xiong; Jesse D Pasternak; Layth Abdulrasool; Lauren Ogawa; Insoo Suh; Jessica E Gosnell; Edwin L Kaplan; Quan-Yang Duh; Peter Angelos; Wen T Shen; Raymon H Grogan
Journal:  Ann Surg Oncol       Date:  2016-08-19       Impact factor: 5.344

4.  Breast carcinoma metastatic to parathyroid adenoma.

Authors:  C I Margolis; V E Goldenberg
Journal:  N Y State J Med       Date:  1969-03-01

5.  Tumor-to-tumor metastasis: malignant melanoma metastatic to parathyroid adenoma.

Authors:  T Inoshita; A R Laurain
Journal:  Mil Med       Date:  1985-06       Impact factor: 1.437

Review 6.  Multiple myeloma presenting with recurrent hypercalcemia in a patient with a history of primary hyperparathyroidism: report of case and review of literature.

Authors:  Hasnain M Khandwala; Markham A Boctor
Journal:  Endocr Pract       Date:  2004 Jul-Aug       Impact factor: 3.443

Review 7.  A case of primary hyperparathyroidism accompanying multiple myeloma.

Authors:  F Otsuka; N Hayakawa; T Ogura; H Kataoka; M Kawashima; Y Mimura; T Yamauchi; N Kashihara; J Kageyama; H Makino
Journal:  Endocr J       Date:  1997-02       Impact factor: 2.349

Review 8.  Primary and metastatic parathyroid malignancies: a rare or underdiagnosed condition?

Authors:  Alexander Shifrin; Virginia LiVolsi; Svetlana Shifrin-Douglas; Min Zheng; Brian Erler; Theodore Matulewicz; John Davis
Journal:  J Clin Endocrinol Metab       Date:  2014-12-09       Impact factor: 5.958

9.  [Hypercalcemia of double origin: association of multiple myeloma and ectopic parathyroidal adenoma].

Authors:  C Fery-Blanco; C Prati; P Ornetti; J Bevalot; G Streit; E Toussirot; D Wendling
Journal:  Rev Med Interne       Date:  2007-03-12       Impact factor: 0.728

10.  A case of multiple myeloma coexisting with primary hyperparathyroidism and review of the literature.

Authors:  Nasir Hussain; Moona Khan; Aparna Natarajan; Mubeenkhan Mohammedabdul; Usman Mustafa; Kalpana Yedulla; Aibek E Mirrakhimov
Journal:  Case Rep Oncol Med       Date:  2013-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.